跳至主要内容
临床试验/NCT02858778
NCT02858778Unknown不适用

A Randomized Allocation of Palliative Care Consultation in the Emergency Department Compared to Usual Practice

Wayne State University4 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
120
试验地点
4
主要终点
The difference in the percentage of patients with a completed advance directive (AD) in Ig vs.Cg

研究概览

简要总结

A prospective randomized controlled trial studying the ordering of palliative care consultations in the emergency department (Ig) versus later palliative care consultations in the hospital--ICU or hospital ward(Cg). Patients will be randomly allocated to Ig or Cg with a 1:1 ratio.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Greater than or equal to 65 years old
  • Treated in a resuscitation room for unstable vital signs or respiratory compromise
  • One or more of the following:
  • Advanced or metastatic solid organ cancer
  • End stage organ failure of the heart, lung/COPD, kidney on dialysis, hepatic encephalopathy
  • Suspected sepsis
  • Advanced dementia, end-state multiple sclerosis or Parkinson's disease
  • Status post cardiac arrest with coma (Glascow coma score <7)
  • Patient is from a skilled nursing facility

排除标准

  • Lack decision capacity and have no relative available during ED stay to consent to the study (legally authorized representative-LAR)
  • Enrolled in hospice care prior to randomization
  • A copy of a completed advance directive which names a designated proxy provided physically to the medical team prior to randomization
  • Wearing a DNR bracelet
  • Have been previously enrolled in this study

结局指标

主要结局

The difference in the percentage of patients with a completed advance directive (AD) in Ig vs.Cg

时间窗: 1 year

次要结局

  • The proportion of billed CMS ACP-CPT codes in Ig vs. Cg(30 days from enrolled patients' hospital discharge)
  • Matches of care received to patient-specific preferences in Ig vs. Cg(1 year)
  • Patient/family satisfaction with care in Ig vs. Cg(Baseline)
  • Amount of hospice referrals in Ig vs. Cg(1 year)
  • Time to consultation in Ig vs. Cg groups(1 year)
  • Hospital total direct costs for the index visit in Ig vs. Cg(1 year)
  • Hospital and ICU length of stay in Ig vs. Cg(1 year)
  • Average days in hospice in Ig vs. Cg(1 year)
  • Hospital margin contribution for the index visit in Ig vs. Cg(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Zalenski

Principle Investigator

Wayne State University

研究点 (4)

Loading locations...

相似试验

已完成
不适用
Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung CancerLung Cancer
NCT03337399Massachusetts General Hospital507
已完成
不适用
Randomized Evaluation of Default Access to Palliative ServicesCOPDDementiaESRD
NCT02505035University of Pennsylvania34,239
已完成
不适用
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterPsychosocial Effects of Cancer and Its TreatmentRecurrent Bladder CancerRecurrent Cervical CancerRecurrent Colon CancerRecurrent Gastric CancerRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorRecurrent Pancreatic CancerRecurrent Rectal CancerRecurrent Renal Cell CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerRecurrent Uterine SarcomaRegional Transitional Cell Cancer of the Renal Pelvis and UreterStage II Bladder CancerStage II Renal Cell CancerStage II Urethral CancerStage IIA Cervical CancerStage IIA Colon CancerStage IIA Gastric CancerStage IIA Ovarian Epithelial CancerStage IIA Ovarian Germ Cell TumorStage IIA Pancreatic CancerStage IIA Rectal CancerStage IIA Uterine SarcomaStage IIB Cervical CancerStage IIB Colon CancerStage IIB Gastric CancerStage IIB Ovarian Epithelial CancerStage IIB Ovarian Germ Cell TumorStage IIB Pancreatic CancerStage IIB Rectal CancerStage IIB Uterine SarcomaStage IIC Colon CancerStage IIC Ovarian Epithelial CancerStage IIC Ovarian Germ Cell TumorStage IIC Rectal CancerStage III Bladder CancerStage III Pancreatic CancerStage III Renal Cell CancerStage III Urethral CancerStage IIIA Cervical CancerStage IIIA Colon CancerStage IIIA Gastric CancerStage IIIA Ovarian Epithelial CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Rectal CancerStage IIIA Uterine SarcomaStage IIIB Cervical CancerStage IIIB Colon CancerStage IIIB Gastric CancerStage IIIB Ovarian Epithelial CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Rectal CancerStage IIIB Uterine SarcomaStage IIIC Colon CancerStage IIIC Gastric CancerStage IIIC Ovarian Epithelial CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Rectal CancerStage IIIC Uterine SarcomaStage IV Bladder CancerStage IV Gastric CancerStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorStage IV Pancreatic CancerStage IV Renal Cell CancerStage IV Urethral CancerStage IVA Cervical CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVA Uterine SarcomaStage IVB Cervical CancerStage IVB Colon CancerStage IVB Rectal CancerStage IVB Uterine SarcomaUreter CancerStage IIA Lung CarcinomaStage IIB Lung CarcinomaStage IIIA Lung CarcinomaStage IIIB Lung Carcinoma
NCT01846520City of Hope Medical Center200
撤回
不适用
Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic NeoplasmPancreatic Neoplasm
NCT06545344Fred Hutchinson Cancer Center40
终止
不适用
LOTCOL Study: Local Treatment of Colo-rectal Liver MetMetastatic Colo-rectal Cancer
NCT01867918Oslo University Hospital3